Kenji Oda

3PUBLICATIONS
4CO-AUTHORS
Epidemiological modellingEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 15, 2026
Correction: Akiyama et al. Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan. J. Clin. Med. 2025, 14, 4697.

|Jul 12, 2025
Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan.

Shoko Akiyama, Kenji Oda, Hiroko Mizohata

|Sep 27, 2023
Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study.

Shigeomi Iimura, Yasuyo Nose, Keiko Tabata

Pageof 1

Frequent Collaborators

2 joint publications

Shoko Akiyama

2 joint publications

Hiroko Mizohata

2 joint publications

Natsuki Sasakura

2 joint publications

Kenichi Hashimoto